Shares of medical device-related companies are trading higher following comments from HCA Healthcare on a conference call that business declines from uninsured patients didn't occur as expected in Q2, which is bullish for the medical device and equipment outlook following the end of ACA subsidies.

8-K filing — BAXTER INTERNATIONAL INC (BAX)

Filed: 2026-08-19 AccNo: 0001193125-26-356188 Size: 323 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Baxter International Announces Appointment Of John Rogers As CFO Effective October 1

FDA Classifies Baxter's Removal Of Certain Duo-Vent Solution Set Lots As Class I Recall Over Air Bubble Risk; Baxter Says No Serious Injuries Or Deaths Reported

Baxter International Says Anita Zielinski To Resign As Interim CFO, Effective September 15, 2026

-SEC Filing

Here's Why You Should Retain Cencora Stock in Your Portfolio for Now

Cencora's U.S. Healthcare Solutions business demonstrated accelerating momentum with 5% revenue growth and 16% operating income growth in Q3, driven by specialty strength and OneOncology's performance. However, the company faces headwinds from manufacturer list-price reductions, the pending MWI divestiture expected to create a $150 million earnings impact, and regulatory uncertainty around 340B and ASP rules. GLP-1 growth and international operations provide diversification opportunities.

Globus Medical Receives CE Mark For Its Excelsius3D Imaging System For Commercial Sale In EU, U.K.

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the European Union and the